A detailed history of Merit Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 47,851 shares of ABBV stock, worth $8.12 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
47,851
Previous 46,688 2.49%
Holding current value
$8.12 Million
Previous $8.01 Million 18.01%
% of portfolio
0.21%
Previous 0.17%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $190,545 - $231,820
1,163 Added 2.49%
47,851 $9.45 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $371,341 - $433,643
2,399 Added 5.42%
46,688 $8.01 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $2.96 Million - $3.37 Million
18,522 Added 71.88%
44,289 $8.07 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $2.04 Million - $2.3 Million
-14,814 Reduced 36.5%
25,767 $3.99 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $287,352 - $332,652
2,151 Added 5.6%
40,581 $6.05 Million
Q2 2023

Aug 01, 2023

BUY
$132.51 - $164.9 $947,313 - $1.18 Million
7,149 Added 22.85%
38,430 $5.18 Million
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $260,876 - $300,438
-1,804 Reduced 5.45%
31,281 $4.99 Million
Q4 2022

Jan 13, 2023

BUY
$138.31 - $165.87 $225,998 - $271,031
1,634 Added 5.2%
33,085 $0
Q3 2022

Oct 31, 2022

SELL
$134.21 - $153.93 $1.08 Million - $1.24 Million
-8,039 Reduced 20.36%
31,451 $4.22 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $3.54 Million - $4.51 Million
25,753 Added 187.47%
39,490 $6.05 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $111,127 - $137,877
842 Added 6.53%
13,737 $2.23 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $23,312 - $29,496
-217 Reduced 1.65%
12,895 $1.75 Million
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $11,491 - $13,044
108 Added 0.83%
13,112 $1.41 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $4,208 - $4,688
40 Added 0.31%
13,004 $1.47 Million
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $97,798 - $107,664
956 Added 7.96%
12,964 $1.4 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $161,060 - $217,448
2,001 Added 20.0%
12,008 $1.29 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $152,318 - $178,771
1,773 Added 21.53%
10,007 $876,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $91,492 - $122,430
1,247 Added 17.85%
8,234 $808,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $16,512 - $25,034
256 Added 3.8%
6,987 $532,000
Q4 2019

Jan 16, 2020

BUY
$72.13 - $90.25 $485,507 - $607,472
6,731 New
6,731 $596,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.